Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses -39.83 K4.19 M737.16 K612.99 K614.69 K390.78 K 2.36 M Research & development —————— — Operating income 39.83 K-4.19 M-737.16 K-612.99 K-614.69 K3.03 M 1.06 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 39.83 K-4.19 M-737.16 K-612.99 K-614.69 K3.03 M 1.06 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 4.02 M-131.89 K3.41 M3.17 M2.76 M3.03 M 12.36 M Discontinued operations —————— — Net income 4.02 M-131.89 K3.41 M3.17 M2.76 M3.03 M 12.36 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 4.02 M-131.89 K3.41 M3.17 M2.76 M3.03 M 12.36 M Basic earnings per share (Basic EPS) 0.0900.080.070.070.07 0.29 Diluted earnings per share (Diluted EPS) 0.0900.080.210.210.07 0.29 Average basic shares outstanding 34.5 M34.5 M34.5 M34.29 M32.92 M32.92 M — Diluted shares outstanding 34.5 M34.5 M34.5 M34.29 M32.92 M32.92 M — EBITDA —————— — EBIT 4.02 M-131.89 K3.41 M15.35 M2.76 M3.03 M 24.55 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —